A Proof-of-Concept Study of Subanesthetic Intravenous Ketamine Combined With Prolonged Exposure Therapy Among Veterans With Posttraumatic Stress Disorder

J Clin Psychiatry. 2020 Nov 10;81(6):20l13406. doi: 10.4088/JCP.20l13406.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Intravenous
  • Adolescent
  • Adult
  • Aged
  • Combined Modality Therapy
  • Excitatory Amino Acid Antagonists / administration & dosage
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Feasibility Studies
  • Humans
  • Implosive Therapy* / methods
  • Ketamine / administration & dosage
  • Ketamine / pharmacology*
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Pilot Projects
  • Stress Disorders, Post-Traumatic / drug therapy
  • Stress Disorders, Post-Traumatic / therapy*
  • Veterans*
  • Young Adult

Substances

  • Excitatory Amino Acid Antagonists
  • Ketamine

Associated data

  • ClinicalTrials.gov/NCT03960658